A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin.
BACKGROUND
Absolute risks of venous thromboembolism (VTE) in protein S-, protein C-, or antithrombin-deficient subjects are mainly based on retrospective data. Screening asymptomatic relatives of these patients is disputed, though studies addressing this issue have yet to be conducted.


METHODS
We prospectively followed 382 relatives of 84 probands. Participants were assessed for other thrombophilic defects and occurrence of exogenous risk factors (i.e. surgery/trauma/immobilization, malignancies, use of systemic estrogens, and pregnancy/puerperium). After screening, deficient subjects were advised to use thromboprophylaxis during exogenous risk factors; use of oral contraceptives was discouraged.


RESULTS
Overall annual incidence of VTE was 1.53% (95% CI, 1.00-2.34) in deficient vs. 0.29% (0.13-0.64) in non-deficient relatives; adjusted hazard ratio, 7.0 (95% CI, 2.7-18.0). Annual incidence of unprovoked VTE was 0.95% in deficient vs. 0.05% in non-deficient subjects; age-adjusted hazard ratio, 22.3 (P = 0.003). In contrast, annual incidence of provoked VTE was 0.58% vs. 0.24%; age-adjusted hazard ratio, 2.8 (P = 0.08). Fifty-five (37%) deficient and 80 (34%) non-deficient subjects experienced 91 and 143 exogenous risk factors, respectively, during which six vs. five VTEs (6.6% vs 3.5% per risk-period) occurred, despite the higher compliance with recommended thromboprophylaxis use in deficient (51%) vs. non-deficient (22%) subjects. In deficient subjects all provoked VTEs occurred when thromboprophylaxis was not used.


CONCLUSIONS
Protein S, protein C or antithrombin deficiencies confer high absolute risk of VTE. Screening and subsequent augmentation of thromboprophylaxis use may result in reduction of provoked VTE, whereas risk of unprovoked VTE could not be affected by screening.
Division of Hemostasis and Thrombosis, Department of Hematology, University Medical Center, Groningen, the Netherlands. b.k.mahmoodi@int.umcg.nl
B K
BK
Mahmoodi
J-L P
JL
Brouwer
M K
MK
Ten Kate
W M
WM
Lijfering
N J G M
NJ
Veeger
A B
AB
Mulder
H C
HC
Kluin-Nelemans
J
J
Van Der Meer
D006801:Humans; D011446:Prospective Studies; D020151:Protein C Deficiency / Q000235:genetics*; D018455:Protein S Deficiency / Q000235:genetics*; D012307:Risk Factors; D019851:Thrombophilia / Q000235:genetics*; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000453:epidemiology*